Clinical and pathological characterization of HER2 mutations in human breast cancer: a systematic review of the literature.

HER2 gene is a member of the epidermal growth factor receptor (EGFR) family. Across different malignancies, aberrations of HER2 gene commonly correspond to gain-of-function alterations leading to increased receptor signaling.